Debkalpa Goswami, PhD
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Debkalpa Goswami, PhD
Debkalpa Goswami, Ph.D. is the Director of Biomechanics at the Cardiovascular Innovation Research Center, in the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute at the Cleveland Clinic. He is an Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. His research group focuses on combining soft robotics, 3D printing, biosensing, and computational tools to build advanced physical and digital biomechanical models of cardiovascular disease.
Dr. Goswami received his Ph.D. from Purdue University and completed his postdoctoral training in Medical Engineering at the Massachusetts Institute of Technology. He has previously held research positions at ETH Zurich, Switzerland, and the University of Bremen, Germany. He was named to the Cleveland Clinic staff in 2023.
Education & Professional Highlights
Appointed
2023
Education & Fellowships
Graduate School - Purdue University
Industrial Engineering
West Lafayette,
IN United States
2020
Undergraduate - Jadavpur University
Production Engineering
Kolkata,
India
2015
Specialty Interests
Cardiovascular biomechanics, soft robotics, 3D printing, wearables
Innovations & Patents
- 3D-architected soft machines with topologically encoded actuation, US Patent #11597101, March 7, 2023.
- Continuous laser nanoforming device, US Patent application, Publication # US20200298342A1, Sept. 24, 2020.
Research & Publications
See publications for Debkalpa Goswami, PhD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 8/1/2023, Dr. Goswami has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
